Search filters

List of works by Margarita Morozova

5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).

scientific article published on 30 January 2017

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia.

scientific article published on 8 July 2010

A Double-Blind, Placebo-Controlled Comparator Study of LY2140023 monohydrate in patients with schizophrenia

scientific article

A change of immune profile of patients with schizophrenia during treatment

scientific article

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

scientific article (publication date: September 2007)

Clinical efficacy and tolerability of tianeptine in treatment of depression (Russian open multicenter trial)

scientific article published in January 2003

Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission.

scientific article published in June 2012

Effect of olanzapine treatment on platelet glutamine synthetase-like protein and glutamate dehydrogenase immunoreactivity in schizophrenia.

scientific article published in January 2006

Effects of the anticholinesterase drug neuromidin in patients with schizophrenia with marked neurocognitive deficits

scientific article

Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

scholarly article published in Nature Medicine

Levels and molecular heterogeneity of serotonin transporter protein in platelets of patients with different mental diseases: a comparative analysis with the use of monoclonal and polyclonal antibodies

scientific article published in January 2001

Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.

scientific article published on 2 December 2009

Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy

scientific article published in January 2005

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRIS

scientific article

Platelet serotonergic parameters and clinical symptoms of psychosis in patients with episodic progressive schizophrenia

scientific article published in January 2007

Possibilities of the treatment of exacerbations of schizophrenia with the long acting atypical antipsychotic paliperidone palmitate

scientific article published on 01 January 2012

SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects.

scientific article published on February 2014

Structural-dynamic analysis of the mechanism of clinical response and treatment prognosis

scientific article published on 01 January 2003

The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders.

scientific article published in March 2001

The ultrastructure of lymphocytes in schizophrenia.

scientific article published in January 2007

[A combination of antidepressants and neuroleptics in the treatment of affective disorders and schizophrenia: indications, side effects and complications]

scientific article published on 01 January 2000

[A historical analysis of "insight" category in psychiatry]

scientific article published on 01 January 2008

[Adrenomodulating effects of human blood, cerebrospinal fluid, urine, saliva, and amniotic fluid]

scientific article published on 01 January 1997

[Clinical characteristics of endogenous affective psychoses with predominantly manic conditions]

scientific article published on 01 January 1989

[Decrease in the platelet level of 43 kDa immunoreactive fraction of serotonin transporting protein correlates with depressive symptoms in patients with somatoform disorders]

scientific article published on 01 May 1999

[Description and validation of a new scale for assessment of autonomy in patients with schizophrenia]

scientific article published on 01 January 2015

[Effect of thymoleptics in aspects of new clinical systematics of depressive syndrome]

scientific article published on 01 January 1997

[Glutamate dysmetabolism in patients with schizophrenia]

scientific article published on 01 January 2007

[Methods for the protection against counterfeit medications. Part 2. The assessment of interlot dispersion of the metoprolol succinate tablets fabricated by different manufacturers]

scientific article published on 01 September 2012

[Methods of adjustment of antipsychotic treatment of the needs of the individual patients with schizophrenia]

[Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation]

scientific article published on 01 January 2015

[Platelet peculiarities in chronic schizophrenic patients]

scientific article published on 01 January 2009

[Psychometrics is not only for experiments]

scientific article published on 01 January 2001

[Relative drug resistance as a result of an erroneous approach to patient care].

scientific article

[The experience of application of olanzapine: an atypical neuroleptic in acute schizophrenia]

scientific article published on 01 January 2000

[The influence of atypical neuroleptics on the immune system of patients with schizophrenia]

scientific article published on 01 January 2007

[The methods for the protection against counterfeit medications. Part 1. The estimation of the quality of metoprolol succinate substance and tablets from different manufacturers in terms of "identity" and "active ingredient content"]

scientific article published in July 2012

[The status of serotonin protein -- a serotonin transporter in thrombocytes in patients with somatoform disorders]

scientific article published on 01 January 1999

[The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features]

scientific article published in January 2014

[Theory and practice of pharmacological treatment of acute schizophrenia: a retrospective study]

scientific article published in January 2014

[Variants of changes in the psychopathological phenomenology of the long-term remission in stable patients with attack-like progressive form of schizophrenia: a longitudinal study]

scientific article published on 01 January 2015